Geoffrey Klass, CEO of Sense Diagnostics. A MedTech startup which has developed technology to detect, measure and monitor neurological disorder of the brain in real time, non-invasively. The initial focus of the company is Stroke and Traumatic Brain Injury. He has a diverse background in banking, finance, medical and pharmaceuticals, held senior executive positions at General Electric and Pfizer